Unclaimed brand
Nexomic uses frontier AI and patient multi-omic data to decode cancer biology and advance precision oncology.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#000DB5
Dark Blue
0, 13, 181
236, 100, 35
100, 93, 0, 29
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#211F34
Steel Gray
33, 31, 52
246, 25, 16
37, 40, 0, 80
Nexomic is a precision oncology company using artificial intelligence and patient multi-omic data to uncover the biology behind cancer treatment response, resistance, and disease evolution. Its large-scale data foundation combines more than five layers of multi-omics with clinically linked outcomes, representing patients across more than 30 countries. Nexomic applies proprietary computational deep profiling and its tumour-agnostic DeepOmic foundation model to translate complex biological signals into insights for drug development and patient care.
The company offers solutions for pharmaceutical and clinical development teams. DECODE helps sponsors assess real-patient tumour biology to de-risk oncology drug development and inform clinical study design. oncoREVEAL uses large-scale AI-driven simulations to predict patient response based on underlying biology rather than diagnosis alone. DeepOmic is designed to create a unified representation of disease biology across omics, patients, and cancer types, supporting validated, clinically relevant analyses. Nexomic’s mission is to better understand tumour heterogeneity and resistance so that treatment decisions can be more precisely matched to patients.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
The Nexomic name, logos and brand assets are trademarks of Nexomic and its affiliates. Brandfetch isn't affiliated with or endorsed by Nexomic. Their use is subject to Nexomic's brand guidelines.
